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Abstract
Background: Clostridium ramosum is a generally non-pathogenic enteric anaerobe, and Fournier’s gangrene is a
rare necrotizing soft tissue infection with male predisposition affecting the perineum and the genital area. We
report, to our knowledge, the first case of Fournier’s gangrene caused by C. ramosum in a female patient with
multiple underlying conditions.
Case presentation: A 44-year-old woman with a 6-year history of insulin-dependent diabetes mellitus after total
pancreatectomy and an 11-year history of central diabetes insipidus developed a pain in the genital area after a
month of urinary catheter use. The lower abdominal pain worsened gradually over 2 weeks, and the pain, general
fatigue, and loss of appetite prompted the patient’s hospital admission. As she had severe edema in her pelvic and
bilateral femoral areas, ceftriaxone was started empirically after collecting two sets of blood cultures. On hospital
day 2, CT examination revealed the presence of necrotizing faciitis in the genital and pelvic areas, and the
antibiotics were changed to a combination of meropenem, vancomycin, and clindamycin. Gram-positive cocci and
gram-positive rods were isolated from blood cultures, which were finally identified as Streptococcus constellatus and
C. ramosum using superoxide dismutase and 16S rDNA sequencing. An emergent surgery was performed on
hospital day 2 to remove the affected tissue. Despite undergoing debridement and receiving combined
antimicrobial chemotherapies, the patient’s clinical improvement remained limited. The patient’s condition
continued to deteriorate, and she eventually died on hospital day 8. In the present case, the underlying diabetes
mellitus, urinary incontinence due to central diabetes insipidus, undernutrition, and edema served as the
predisposing conditions.
Conclusions: C. ramosum is a potentially opportunistic pathogen among immunosuppressed persons and a rare
cause of necrotizing fasciitis.
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Background
Clostridium ramosum belongs to the genus Clostridium,
a group of Gram-positive, spore-forming obligate anaer-
obes, currently known as Erysipelactoclostridium [1]. C.
ramosum is a component of the normal intestinal flora
[2] and has been rarely recognized as an etiologic agent
of infectious diseases when isolated from clinical speci-
mens [3].
Fournier’s gangrene is a form of necrotizing fasciitis or
gangrene affecting the genital area. Shock and organ
failure based on bacteremia frequently accompany gas
gangrene, and the mortality rate is reported to be high
around 50% in classical reports [4]. The most common
pathogens of Fournier’s gangrene include Escherichia
coli and Bacteroides. Clostridium species have been
reported as the pathogen in approximately 10% of the
cases of Fournier’s gangrene [5]. To date, only one case
of gas gangrene caused by C. ramosum has been re-
ported in the literature [6]. In the previous case reported
in 1999, gas gangrene occurred in the neck and thorax,
which is different from Fournier’s gangrene.
The underlying conditions help determine the progno-
sis of Fournier’s gangrene. Fournier’s gangrene com-
monly occurs in elderly men and rarely in women and is
more likely associated with worse outcomes in individ-
uals who are immunocompromised, such as those with
diabetes. Treatments of patients with Fournier’s gan-
grene include the use of antibiotics and prompt surgical
debridement. The diagnosis is suspected when gas in the
deep tissue including the fascia is recognized by a com-
puted tomography (CT) or magnetic resonance imaging
(MRI) scan with systemic findings compatible with in-
fection. It should be recognized as a condition that does
not fall into the general category of “acute abdomen” but
necessitates an urgent surgical referral.
We report a fatal case of Fournier’s gangrene caused by
C. ramosum with Streptococcus constellatus in a patient
with central diabetes insipidus and insulin-dependent dia-
betes mellitus. The infection had progressed for a few
weeks and had subsequently rapidly worsened, taking a le-
thal course despite multimodal treatment.
Case presentation
A 44-year-old Japanese woman with a 6-year history of
insulin-dependent diabetes mellitus and an 11-year his-
tory of central diabetes insipidus presented with a pain
in the genital area worsening over 2 weeks, general fa-
tigue, and loss of appetite. Two months earlier, patient
underwent a urinary catheter insertion as a management
for urinary frequency, but it was removed during the
previous hospital stay, a month before her recent
hospitalization, for possible urinary infection. She has had
frequent hospital admissions (6 times/year) and was hos-
pitalized 3 months before her recent admission because of
edema of the pelvic area and lower limbs. The patient de-
veloped diabetes mellitus after undergoing total pancrea-
tectomy for nesidioblastosis, a surgical procedure which
involved the removal of patient’s pancreas including the
spleen and gallbladder. Her sister was also diagnosed with
idiopathic central diabetes insipidus; thus, a family eti-
ology was suspected. The patient had a surgery for sus-
pected tongue cancer 2 years ago and was also suspected
of non-alcoholic steatohepatitis with episodes of hepatic
encephalopathy. Although she was on multiple medica-
tions including subcutaneous insulin injections and des-
mopressin tablets, her glycemic and hydration status were
poorly controlled.
Four days prior to the present admission, she visited a
gynecologist for her inguinal pain. No uterine tenderness
or exudate was observed, and she was prescribed genta-
micin and lidocaine ointments for possible local infec-
tion. She developed edema in the pelvic area with loss of
appetite, and her home doctor consulted the university
department 1 day before the present admission.
Upon admission, the patient appeared weak but was
alert and had low-grade fever (37.4 °C) under a regular
use of acetaminophen (1500 mg/day) and diclofenac
(75 mg/day). Her blood pressure was not significantly
different from previous measurements (88/42 mmHg)
but a sinus tachycardia (heart rate 125/min) was noted.
She complained of continuous abdominal pain and ten-
derness in all four quadrants. No abdominal guarding or
rigidity was observed, but she had severe edema in the
pelvic and bilateral femoral areas without necrotic skin
discoloration. Laboratory investigations revealed a white
cell count of 16,310/μL with neutrophilia (90.8%), ele-
vated C-reactive protein of 22.18 mg/dL, and no serum
sodium or potassium abnormalities. Serum aspartate
aminotransferase and alanine aminotransferase were ele-
vated at 466 U/L and 148 U/L, respectively. The patient’s
international normalized ratio was high (2.26), but dis-
seminated intravascular coagulation score did not meet
the criteria. The patient’s HbA1c level was 8.8%, and
blood sugar at admission was 316 mg/dL. She had low
serum albumin concentration (1.7 g/dL), elevated serum
ammonia concentration (154 μg/dL), and elevated lac-
tate level (10.3 mmol/L). No ketonuria was noted, but
significant pyuria was observed.
The abdominal ultrasound was unrevealing; thus, an
intravenous treatment with ceftriaxone (1 g every 8 h)
was initiated empirically after obtaining the blood and
urine culture samples. A CT scan performed the follow-
ing morning revealed the presence of air in the soft tis-
sue of the inguinal and pelvic areas, such as pectineal
and psoas major muscles (Fig. 1). Immediate infectious
and surgical consultations were made, and the antibi-
otics were changed to meropenem (1 g every 8 h),
vancomycin (1 g every 12 h), and clindamycin (600 mg
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every 8 h). Gram-positive cocci and gram-positive rods
were found in the initial blood cultures. In the evening of
hospital day 2, a surgical debridement of the extraperito-
neal pelvic tissue with colonostomy was performed, and
the CT image after the operation suggested a complete
resection of the affected tissue. However, hypernatremia
(a serum Na concentration of 160 to 170 mEq/L)
ensued as the use of nasal desmopressin could not
effectively control the patient’s central diabetes insipidus
after the operation.
No bacteria could be cultured from the debridement
tissues (Table 1). The blood culture isolates were finally
identified as Streptococcus constellatus using superoxide
dismutase A sequencing and C. ramosum by 16S riboso-
mal DNA sequencing [7]. The minimum inhibitory con-
centrations (MICs) of various antibiotics were tested
using Etest for C. ramosum [8] and the broth microdilu-
tion method [9] except imipenem and meropenem
(Etest) for S. constellatus (Table 2). These results were
interpreted using the Clinical & Laboratory Standards
Institute M11-A8 document [10] for C. ramosum and
M100-S24 document for S. constellatus. Both strains
were susceptible to penicillin, meropenem, and clinda-
mycin. Despite the continued use of susceptible antibi-
otics and intensive care, disseminated intravascular
coagulation and pancytopenia developed, and the patient
died on hospital day 8.
Discussion and conclusions
Fournier’s gangrene is a very rare and severe infection
affecting the soft tissues of the genital and pelvic areas.
In a population-based study, the overall incidence was
estimated to be 1.6 in 100,000 men, and it is expected to
be much lower in women, as the study identified only 39
female patients as opposed to 1461 male patients [11].
However, the female ratio may be higher, as a recent
study reported 20.2% female among 124 Founier’s gan-
grene patients [12]. Also, in a recent report, 9249 Four-
nier’s gangrene patients were identified for a weighted
estimate of 43,146 cases using the National Inpatient
Sample, and this study reported a mortality rate of 4.7%,
which is lower than those of most previous reports [13].
Scoring systems have been proposed to establish a
timely diagnosis and predict outcome of Fournier’s gan-
grene. One such system, Uludag Founier’s Gangrene
Severity Index (UFGSI), evaluates the physiological sta-
tus, age, and extent of the gangrene, and is reported to
be more powerful than FGSI, another scoring system for
Fournier’s gangrene that can predict mortality with a
78% probability and survival with a probability of 78%
Fig. 1 Computed tomography image of the lower-abdominal area
before the surgery
Table 1 Wound and other culture results
Source Microbe Quantity
Urine Klebsiella pneumoniae subsp.
pneumoniae
10^8
Staphylococcus aureus (MSSA) 10^3
Wound swab in the
genital areaa
Negative
Vaginal fluida Aerobic GPR 2+
Candida albicans 2+
Candida glabrata few
Fermentative GNR few
Staphylococcus aureus (MSSA) few
aSamples taken after the start of antimicrobial agents
Table 2 Antimicrobial susceptibility profiles of C. ramosum and
S. constellatus strains
Antibiotics MIC (mg/L) and interpretation of susceptibility
C. ramosum S. constellatus
Benzylpenicillin 0.023 S 0.06 S
Ampicillin 0.047 S ND
Ampicillin/sulbactam 0.032 S ND
Piperacillin/tazobactam 0.094 S ND
Cefoxitin 64 R ND
Ceftriaxone 0.5 NA 0.5 S
Imipenem 0.25 S 0.094a NA
Meropenem 1 S 0.125a S
Clindamycin 0.75 S ≤0.125 S
Erythromycin > 256 NA ≤0.125 S
Tetracycline 32 NA 0.5 S
Levofloxacin > 32 NA 0.5 S
Moxifloxacin > 32 R ND
Vancomycin 4 NA 1 S
Linezolid 4 NA 0.5 S
Metronidazole 0.75 S ND
NA not applicable, ND not done, S susceptible, R resistant
a results using Etest
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[14]. UFGSI score greater than 9 resulted in a 94% prob-
ability of death in contrast to a score of 9 or less that
showed a high survival probability of 81% [15]. Our pa-
tient had FGSI score of 8 and UFGSI score of 14 upon
admission, which increased to 12 and 18, respectively, at
the time of debridement because electrolytes fluctuated
due to central diabetes insipidus, and the prognosis was
poor at that point.
In the present case, many possible underlying fac-
tors were identified: susceptibility to infection due to
diabetes mellitus and undernutrition, the history of
splenectomy, and compromised skin and mucosal bar-
riers due to edema, incontinence, and urinary catheter
placement for central diabetes insipidus. In addition,
hypernatremia due to central diabetes insipidus com-
plicated the postoperative management.
Moreover, the subacute onset of Fournier’s gangrene
in this patient may have delayed the definite diagnosis.
The presence of pain for 2 weeks suggested a less ful-
minant progression, but the condition was more severe
internally than it seemed externally at presentation.
In the present case, the C. ramosum was isolated from
the blood of a patient with Fournier’s gangrene for the
first time in literature. C. ramosum cultures were also
found in children with ear infections and in older adults
with co-morbidities, sometimes forming abscesses [16].
The identification of C. ramosum in culture may be diffi-
cult: C. ramosum has a variability in Gram stain positiv-
ity, weak spore formation, and atypical clostridial colony
morphology [17]. Molecular identification should be
considered to identify suspected species of C. ramosum.
As for the pathogenic potential of C. ramosum, IgA
protease of C. ramosum is able to degrade both IgA1
and IgA2, which helps the evasion of the microbe from
the host immune defense to penetrate in to the deep
tissue [2]. This IgA protease, cloned in 2002 [18], is not
found in other Clostridium species. Because C. ramosum
is among the normal intestinal flora, C. ramosum in this
case may have entered the deep tissue of the genitalia
via the intestinal mucosa. It is difficult to assess the
pathogenic role of C. ramusum, but the blood cultures
also yielded S. constellatus, a part of the S. anginosus
group (formerly “S. milleri”) that causes various ab-
scesses in humans and is often involved in polymicrobial
infections with obligate anaerobes [19]. Anaerobes can
enhance the growth of S. constellatus and inhibit the
bactericidal activity of the host [20, 21]. In this case, the
severity of the clinical course might be due to the syner-
gistic infection of the C. ramosum and S. constellatus.
Although antibiotic resistance is uncommon in C. ramo-
sum, a 74% resistance to clindamycin was reported in
one study [3]. In our case, this C. ramosum strain
showed resistance to moxifloxacin and cefoxitin, but was
susceptible to meropenem and clindamycin and showed
low MIC of the initial antibiotic used, ceftriaxone. S. con-
stellatus was also susceptible to ceftriaxone, meropenem,
vancomycin, and clindamycin. The reason for the lethal
course despite the use of multiple susceptible antibiotics
combinations may be due to the uncontrollable progres-
sion of invasion with poor host-defense mechanism.
In conclusion, to our knowledge, we report the first
case of Fournier’s gangrene with C. ramosum in a female
patient with multiple comorbidities. The condition was
more severe than it seemed at presentation, and the
disease progressed rapidly despite multimodal treatment.
The accumulation of more information on C. ramosum
infections and gangrene may lead to the identification of
the disease patterns and methods for timely diagnosis
and treatment.
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